West HealthGallupMosaic
West Health mosaic Logo
Article

Expanding GLP-1 Access Under The BALANCE Model: Supporting Sustainable Medicaid Participation

November 18, 2026
Time to read icon
1 Minute Read

Can states afford to say yes to cheaper GLP-1s? CMS’s BALANCE Model negotiates lower GLP-1 prices for Medicaid programs that agree to cover the drugs for weight loss, alongside lifestyle supports. But lower prices alone may not be enough to bring states on board. Uncertainty about how many people will use the drugs, how much it will cost state budgets, and whether savings will show up in the long run could hold states back. This Health Affairs Forefront piece looks at what’s getting in the way and suggests changes that could make participation workable.

To read the original article posted on Health Affairs, click the button below.